Magnesium Deficiency In Patients Hospitalized in Internal Medicine Wards

PHASE4RecruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Hypomagnesemia
Interventions
DRUG

Magnesium Citrate 100 MG

initial intravenous treatment: Patients with magnesium levels 1-1.5 mg/dL will receive 2-4 grams of magnesium sulfate in the first 24 hours. Patients with magnesium levels 1.6-1.9 mg/dL will receive 1 gram of magnesium sulfate. participants with magnesium level ≥1 mg/dL, will be randomized, and oral magnesium therapy, Magnesium Citrate, ( or no treatment) will be started, and continued for at least three months. The experimental group will receive 400mg magnesium daily in two divided doses.

Trial Locations (1)

Unknown

RECRUITING

Emek Medical Center, Afula

All Listed Sponsors
lead

Frieda Wolf

OTHER